VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 52 filers reported holding VOR BIOPHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $745,055 | -31.3% | 351,441 | +0.2% | 0.00% | – |
| Q2 2023 | $1,083,830 | +197.9% | 350,754 | +418.6% | 0.00% | – |
| Q1 2023 | $363,882 | +48.8% | 67,636 | +83.9% | 0.00% | – |
| Q4 2022 | $244,554 | +165.8% | 36,775 | +59.0% | 0.00% | – |
| Q3 2022 | $92,000 | -2.1% | 23,122 | +21.5% | 0.00% | – |
| Q2 2022 | $94,000 | -89.3% | 19,026 | -86.9% | 0.00% | – |
| Q1 2022 | $875,000 | -50.5% | 144,967 | -4.6% | 0.00% | – |
| Q4 2021 | $1,766,000 | -26.4% | 151,926 | -0.7% | 0.00% | – |
| Q3 2021 | $2,400,000 | +15.9% | 153,051 | +37.9% | 0.00% | – |
| Q2 2021 | $2,070,000 | -60.6% | 110,978 | -9.0% | 0.00% | -100.0% |
| Q1 2021 | $5,256,000 | – | 121,954 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 6,361,723 | $38,425,000 | 8.39% |
| OUP Management Co., LLC | 374,714 | $2,263,000 | 1.72% |
| RA Capital Management | 11,120,973 | $67,171,000 | 1.47% |
| Paradigm Biocapital Advisors LP | 894,404 | $5,402,000 | 1.43% |
| JOHNSON & JOHNSON | 1,074,658 | $6,491,000 | 1.23% |
| Sarissa Capital Management LP | 707,010 | $4,270,000 | 0.40% |
| Artal Group S.A. | 550,000 | $3,322,000 | 0.14% |
| Woodline Partners LP | 1,111,123 | $6,711,000 | 0.11% |
| Orbimed Advisors | 833,333 | $5,033,000 | 0.08% |
| Laurion Capital Management LP | 857,308 | $5,178,000 | 0.06% |